IQVIA.COM
United Kingdom
Choose a Region Contact Us
Explore IQVIA by region
As a global community, IQVIA continuously invests and commits to advancing human health.
Americas
Argentina Brazil Canada Central America and Caribbean Colombia Ecuador Mexico United States
Europe
Adriatic Nordics Belgium Poland Bulgaria Portugal Czech Republic Romania France Russia Germany Slovakia Greece Spain Hungary Switzerland Ireland Turkey Israel Ukraine Italy United Kingdom Netherlands
Asia & Oceania
Asia Pacific Australia & NZ China India Japan Korea Southeast Asia Sri Lanka
Middle East & Africa
Middle East and Africa
Regional Thought Leadership
US Insights
EMEA Thought Leadership
Asia Pacific Insights
Choose a Region Contact Us
Explore IQVIA by region
As a global community, IQVIA continuously invests and commits to advancing human health.
Americas
Argentina Brazil Canada Central America and Caribbean Colombia Ecuador Mexico United States
Europe
Adriatic Nordics Belgium Poland Bulgaria Portugal Czech Republic Romania France Russia Germany Slovakia Greece Spain Hungary Switzerland Ireland Turkey Israel Ukraine Italy United Kingdom Netherlands
Asia & Oceania
Asia Pacific Australia & NZ China India Japan Korea Southeast Asia Sri Lanka
Middle East & Africa
Middle East and Africa
Regional Thought Leadership
US Insights
EMEA Thought Leadership
Asia Pacific Insights
  1. Solutions
  2. Insights
MAIN/Solutions
Solutions/
SOLUTIONS
  • NHS Solutions
  • Life Sciences Industry
  • Advancing UK Healthcare
  • Pharmacy Communications
NHS Solutions

Utilising the extensive range of data assets exclusively available to IQVIA, combined with our market leading expertise, we are able to support the NHS meet the challenge of delivering high quality, efficient and cost effective healthcare by identifying actionable insight and realising the value in data.

Learn More
NHS Solutions
Life Sciences Industry

We believe in the UK’s potential to become a global leader in the life sciences sector, and our investments announced in the 2018 Second Life Sciences Sector Deal further support the UK Government and the industry’s aim to make that potential a reality.

Learn More
Life Sciences Industry Solutions
Advancing UK Healthcare

We are committed to providing solutions that inform and enable all stakeholders across UK healthcare, to innovate with confidence, maximise opportunities, and, ultimately, drive human health outcomes forward.

Learn More
Advancing UK Healthcare Solutions
Pharmacy Communications

IQVIA’s Pharmacy Communications offers pharma companies a simple and cost-effective channel to communicate product changes, updates and patient advice directly to patients via pharmacists.

Learn More
MAIN/Insights
Insights/
BLOGS, WHITEPAPERS & CASE STUDIES

Explore our library of resources spanning the healthcare & life science ecosystem on the latest topics, trends, and market developments that matter to you.

Learn More
NEWSROOM

Stay up to date on the latest news and press releases from IQVIA UK & Ireland.

Learn More

Report

"Our commitment to sustainability.

Learn More
Oncology Dynamics

Pharmacotherapy Observatory Antitumour agents

Contribute to advances in oncology research!
Are you a haematologist, oncologist, radiotherapist or urologist practising in the UK and are you directly involved in the decision-making process regarding oncological treatments of patients.

Contact us
Locations United Kingdom IQVIA Medical Studies Oncology Dynamics

Objectives of the study

Analyse the outlook for cancer treatments in the UK and in more than 20 other countries.

Doctor with Female Patient

Data collected

Each quarter, numerous oncology specialists practising in the UK & Ireland share their expertise to enrich our understanding of the oncological decision-making process.

These collaborating physicians participate by sharing anonymous data on patients they have treated over a 14-day period, in accordance with GDPR.

Data collection is carried out securely and easily via intuitive online questionnaires, designed to be completed in just 7 to 12 minutes per patient record.

Find the accepted diagnoses for each speciality as well as the number of questionnaires to report.

Urologist

Urologist

18 patients treated with antitumor drug treatments

Patients diagnosed with one of the following tumour types:

  • Penal
  • Prostate
  • Testicular
  • Renal
  • Urethral
  • Bladder
  • Related to other components of the urinary tract

Haematologist

Haematologist

20 patients treated with antitumor drug treatments

Patients diagnosed with one of the following tumour types:

  • Hodgkin's disease
  • Non-Hodgkin's lymphoma
  • Immune proliferative diseases
  • Multiple myeloma and malignant plasma cell tumors
  • Lymphocytic leukemia
  • Myeloid leukemia
  • Monocytic leukemia
  • Other types of leukemia
  • Other lymphoid malignancies
  • Hematopoietic and related tissue tumors
  • Polycythaemia vera
  • Myelodysplastic syndromes

Oncologist

Oncologist

29 patients treated with anti-tumour pharmacotherapy

Diagnosed with one type of tumour (Minimum 2 different types of cancer)

Radiotherapist

Radiotherapist

28 patients treated with antitumor pharmacotherapy

Diagnosed with one type of tumor (Minimum 2 different types of cancer)

Join us!

Easy participation

Participate in our study once a quarter according to your availability and complete the questionnaires in just a few clicks thanks to our intuitive drop-down menus!

Guaranteed data confidentiality

Log in to our online platform securely and complete our questionnaires in compliance with GDPR. No personal data is collected as part of this study.

Advantageous financial compensation

As a thank you for your time and for sharing your expertise, you will be awarded a financial reward for each participation. Payment will be made promptly to an IQVIA Healthcare Research Partner Program Visa® prepaid card within a maximum of 2 business days following your participation.
A MAJOR CONTRIBUTION
Would you like to participate?
If you're based in mainland UK and play a direct role in shaping oncology treatment decisions, we invite you to join us in driving meaningful progress in cancer care. Your expertise can help accelerate breakthroughs and improve outcomes for patients nationwide.

Email: oncologypanelstudies@iqvia.com
Phone: 0805 639 870 (cost of a local call)
Contact us
Contact Us